Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

Augmentation of endogenous cannabinoid (eCB) signaling represents an emerging approach to the treatment of affective disorders. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid to form prostaglandins, but also inactivates eCBs in vitro. However, the viability of COX-2 as a therapeutic target for...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hermanson, Daniel J., Hartley, Nolan D., Gamble-George, Joyonna, Brown, Naoko, Shonesy, Brian C., Kingsley, Phillip J., Colbran, Roger J., Reese, Jeffrey, Marnett, Lawrence J., Patel, Sachin
Format:	Artigo
Language:	Inglês
Published:	2013
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3788575/ https://ncbi.nlm.nih.gov/pubmed/23912944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3480
Tags:	Add Tag No Tags, Be the first to tag this record!

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

Similar Items